These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11668978)
1. U.S., Switzerland oppose developing-country proposal on access to medicines. James JS AIDS Treat News; 2001 Sep; (371):5. PubMed ID: 11668978 [No Abstract] [Full Text] [Related]
2. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related]
3. Access to essential drugs. Dev World Bioeth; 2001 Nov; 1(2):89-92. PubMed ID: 12870517 [No Abstract] [Full Text] [Related]
4. Access to AIDS medicines stumbles on trade rules. Wise J Bull World Health Organ; 2006 May; 84(5):342-4. PubMed ID: 16710536 [No Abstract] [Full Text] [Related]
5. WTO accepts rules limiting medicine exports to poor countries. James JS AIDS Treat News; 2003 Sep; (394):2-6. PubMed ID: 14669728 [TBL] [Abstract][Full Text] [Related]
6. The morally uncomfortable global drug gap. Cohen-Kohler JC Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710 [TBL] [Abstract][Full Text] [Related]
7. India changes patent law to meet WTO treaty, making new medicines less available to most citizens, other countries. James JS AIDS Treat News; 2004; (407-408):6-7. PubMed ID: 15717384 [TBL] [Abstract][Full Text] [Related]
8. MeTA: a welcome force for access to medicines. Lancet; 2008 May; 371(9626):1724. PubMed ID: 18502276 [No Abstract] [Full Text] [Related]
9. Unfair competition under the TRIPS agreement: protection of data submitted for the registration of pharmaceuticals. Correa CM Chic J Int Law; 2002; 3(1):69-85. PubMed ID: 15709300 [No Abstract] [Full Text] [Related]
10. US changes trade policy on essential medicines. Yamey G BMJ; 1999 Dec; 319(7224):1521. PubMed ID: 10591704 [No Abstract] [Full Text] [Related]
11. From the World Health Organization. Essential medicines: 25 years of better health. JAMA; 2002 Dec; 288(24):3102. PubMed ID: 12495381 [No Abstract] [Full Text] [Related]
12. How poor countries can gain access to cheap drugs. Fleck F BMJ; 2003 Sep; 327(7416):642. PubMed ID: 14500433 [No Abstract] [Full Text] [Related]
13. TRIPS, pharmaceuticals, developing countries, and the Doha "solution". Sykes AO Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299 [No Abstract] [Full Text] [Related]
14. Drug donations to developing countries. Khare AK World Hosp Health Serv; 2001; 37(1):18-9, 33-4. PubMed ID: 11372253 [TBL] [Abstract][Full Text] [Related]
15. The concept of essential medicines: lessons for rich countries. Hogerzeil HV BMJ; 2004 Nov; 329(7475):1169-72. PubMed ID: 15539676 [TBL] [Abstract][Full Text] [Related]
16. No deal in sight on cheap drugs for poor countries. Fleck F BMJ; 2003 Mar; 326(7387):465. PubMed ID: 12609924 [No Abstract] [Full Text] [Related]
17. World's poorest countries can improve access to medicines through local production, says United Nations. Zarocostas J BMJ; 2011 May; 342():d3101. PubMed ID: 21593099 [No Abstract] [Full Text] [Related]
18. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards. Cohen-Kohler JC; Forman L; Lipkus N Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618 [TBL] [Abstract][Full Text] [Related]
19. A prescription for drug delivery. Affolder R; Rizzo I; Burgess C; Bchir A; Lob-Levyt J Nature; 2007 Sep; 449(7159):170-2. PubMed ID: 17851513 [No Abstract] [Full Text] [Related]
20. Donation of medicines to developing countries. Smego RA; Gebrian B Clin Infect Dis; 1994 May; 18(5):847-8. PubMed ID: 8075299 [No Abstract] [Full Text] [Related] [Next] [New Search]